Calpain small subunit 1 (Capn4) has been shown to correlate with the metastasis/invasion of clear cell renal cell carcinoma (ccRCC). This study aimed to further elucidate the molecular mechanisms underlying Capn4-mediated ccRCC progression. The mRNA expression levels in ccRCC cells were measured by quantitative real-time PCR. The effects of Capn4 on cell adhesion, invasion, and migration were examined by cell adhesion assay, cell invasion assay, and wound-healing assay, respectively. The protein levels were detected by western blot analysis. The effect of Capn4 on cancer metastasis in vivo was assessed in a nude mice xenograft model. It was found that Capn4 was up-regulated in the ccRCC cells, and Capn4 overexpression suppressed cell adhesion activity and increased cell invasion and migration in 786-O cells, while Capn4 silencing increased cell adhesion activity and impaired the invasion and migration ability of Caki-1 cells. Capn4 overexpression also increased the protein level of cleaved talin in 786-O cells, while Capn4 silencing decreased the protein level of cleaved talin in Caki-1 cells. The focal adhesion kinase (FAK)/AKT/MAPK signaling was activated by Capn4 overexpression in 786-O cells, and was inhibited by Capn4 down-regulation in Caki-1 cells. Capn4 overexpression increased the protein levels of matrix metalloproteinase 2 (MMP-2), vimentin, N-cadherin, and downregulated E-cadherin in 786-O cells, while Capn4 silencing decreased the protein levels of MMP-2, vimentin, N-cadherin, and up-regulated E-cadherin in Caki-1 cells. Capn4 also promoted cancer metastasis in the in vivo nude mice xenograft model. Our results implicate the functional role of Capn4 in ccRCC invasion and migration, which may contribute to cancer metastasis in ccRCC.
Introduction
Renal cancer accounts for~2%-3% of all the human cancers worldwide, and clear cell renal cell carcinoma (ccRCC) accounts for 75% of all renal malignancies [1] . For the affected patients,~50%
patients have metastasis with local tissues invaded. In addition, these patients are resistant to radiation and common chemotherapy. Recently, new therapeutic approaches including targeted drugs or immune checkpoint inhibitors have improved the clinical management of ccRCC. However, the 5-year survival rates for patients with metastasis are still very low, only~8%-12% [2, 3] . In this regard, to clarify the exact mechanism involved in the ccRCC metastasis is important for the development of novel therapies for ccRCC.
Cancer metastasis is a complex and multistep process, including tumor cells dissociating from the origin, extracellular matrix degradation, cell migration and growth, apoptosis evasion, angiogenesis, invasion of surrounding tissues, and cell movement to the distant sites in the body [4] . Integrin, an important adhesion receptor for extracellular matrix, has been reported to promote cell adhesion, motility, and invasion during metastatic progression [5] . In addition, integrin exerts its function via focal adhesion kinase (FAK) activation and the downstream pathways, including the Ras/MAPK and PI3K/Akt signaling [6] . During the progress, talin, a cytoskeletal protein, is the crucial regulator of integrin activation and most of the crosstalk is influenced by talin. The linkage between integrin to the actin cytoskeleton is mediated by talin, which is important for cell adhesion and the motility [7] . Recently, talin was found to suppress E-cadherin expression, which negatively correlates with cancer progression, indicating a role of talin in tumor metastasis [8] . Consistently, evidence also showed that overexpression of talin1 promoted prostate cancer cell migration and invasion [9] . In addition, the active FAK promotes cell motility by interaction with talin signaling, which drives cytoskeletal remodeling and cell-surface presentation of matrix metalloproteinases, and enhances cell invasion and tumor metastasis [10] .
Recently, calpains have been suggested to involve numerous physiological and pathological processes. The calpains consist of a large subunit (Capn1 and Capn2 encoded) and a small one (Capn4, 28-kDa) [11] . To regulate cell spreading and migration, calpain localizes to integrin clusters and cleaves focal adhesion proteins, including FAK and talin. It was reported that in the Capn4 − / − embryonic fibroblasts, proteolysis of talin was not detected. Moreover, talin cleavage was restored when an overexpressed 28-kDa calpain small subunit was transfected [12] , indicating that Capn4 may regulate cell migration through integrin signaling and talin may be the downstream regulator of Capn4. Calpain activity is also critical for tumor invasion. As a subunit of calpain, Capn4 plays an essential role in the tumor metastasis. In previous studies, overexpression of Capn4 was observed in intrahepatic cholangiocarcinoma and ccRCC, and positively correlated with lymphatic metastasis and the tumor node metastasis stage [13, 14] . The study on Capn4 in ccRCC is rare. In this study, we aimed to examine the potential role of Capn4 in ccRCC cells and to explore downstream signaling pathways (talin/FAK) that could be affected by Capn4 in ccRCC cells, thereby to elucidate the mechanisms of Capn4-mediated metastasis in ccRCC.
Materials and Methods

Cell culture and transfection
The human kidney proximal tubular cell line (HKC) and the clear cell renal carcinoma cell lines including 786-O, ACHN, Caki-1, and Caki-2 were obtained from ATCC (Manassas, USA). All cells were cultured in RPMI 1640 medium (Sigma, St Louis, USA) containing 10% fetal bovine serum (FBS; Sigma) at 37°C in a humidified atmosphere with 5% CO 2 . For Capn4 overexpression, the Capn4-overexpressing vector, pcDNA3.1-Capn4, and the control vector, pcDNA3.1 were purchased from GeneChem Company (Shanghai, China). Capn4 siRNA (sense, 5′-UCAUUUGAUAUGUAGAUGCCC-3′;
antisense, 5′-GCAUCUACAUAUCAAAUGACG-3′), FAK siRNA (sense, 5′-GCGAUUAUAUGUUAGAGAUAG-3′; antisense, 5′-CGCUAAUAU ACAAUCUCUAUC-3′), and the respective control nonsense siRNAs (Capn4: sense, 5′-GUUAAUCUCAAUCGCUAGUGU-3′; antisense, 5′-GUACCUCUCAAUAACGUAAGA; FAK: sense, 5′-GAUAUGU GAAGUUAAGGUCUA-3′; antisense, 5′-GCCUUACUCAUAUCU AAUACA-3′) were purchased from GenePharma (Shanghai, China). Transfection was performed by using the Lipofectamine 2000 (Invitrogen, Carlsbad, USA) according to the manufacturer's instructions. The cells were collected at 24 h post-transfection.
RNA isolation and quantitative real-time PCR
Total RNA was extracted from tissues and cells by using TRIzol reagent (Takara, Dalian, China) following the manufacturer's instructions. Total RNA was reverse-transcribed to complementary DNA (cDNA) using the commercial kit (Takara). Quantitative real-time PCR (qRT-PCR) was performed with SYBR Green Real-Time PCR Master Mixes (Takara) on an ABI 7900 PCR System (Applied Biosystems, Foster City, USA). The primers were as follows: Capn4: forward, 5′-CCCCCACGCACACATTA-3′ and reverse, 5′-CGCTAT CCATCACGGCCACCAT-3′; FAK: forward, 5′-AATCGGCCCAG AAGAAGGAA-3′ and reverse, 5′-CGCAATGGTTAGGGATGGTG-3′; and GAPDH: forward, 5′-GAAGGTGAAGGTCGGAGTC-3′ and reverse, 5′-GAAGATGGTGATGGGATTTC-3′. GAPDH was used as the internal control.
Cell adhesion assay
Cells were seeded in a 96-well plate coated with human fibronectin at a density of 4 × 10 4 cells/well. One hour post-incubation at 37°C, the cells were rinsed with 10% formalin and stained with crystal violet in dark for 5 min at room temperature. Then, the cells were washed with ddH 2 O and dissolved in 100 μl of 33% acetic acid, followed by shaking for 10 min in a horizontal shaker. Absorbance was detected at 560 nm using a microplate reader (BioTek, Winooski, USA). At least, three replicate cell cultures of each treatment were examined in the experiment.
Transwell invasion assay
Cells were seeded in the upper transwell chambers with 8-μm pore size membrane inserts (Corning Co., Corning, USA) coated with Matrigel. The upper chamber contained RPMI 1640 medium without FBS, and the lower chambers were filled with 1 ml full medium. After incubation for 24 h in the incubator, cells of the upper layer were removed and the migrated cells were fixed and stained with Giemsa. At least four fields of each membrane were counted under a microscope. The number of invading cells was the average number in each field per well.
Wound healing assay
Cells were seeded in 6-well plates with the density of 5 × 10 5 cells/ well. A wound was created using a 200-μl pipette tip. The culture was washed with phosphate buffered saline to remove the scratched cells. After incubation for 24 h, cells were photographed under a phase-contrast microscope and the wound condition was analyzed. Data was shown as % of wound closure = (wound width at 0 hwound width at 24 h)/wound width at 0 h×100%.
Western blot analysis
Tissues from mice as well as cells were collected and protein concentrations were determined by BCA Protein Assay Kit (Bio-Rad, Hercules, USA). A total of 30 μg protein was separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred onto polyvinylidene difluoride membranes. The membranes were blocked with 5% skim milk for 1 h at room temperature and then incubated with respective primary antibodies at 4°C overnight. After three times wash with phosphate buffered saline with Tween 20, the membrane was incubated with horseradish peroxidase-conjugated secondary antibodies (1:2000; Santa Cruz Biotechnology, Santa Cruz, USA) at room temperature for 1 h. Finally, protein bands were visualized using the enhanced chemiluminescence kit (Roche, Basel, Switzerland). β-Actin was used as the internal control. Primary antibodies used were as follows: rabbit anti-Capn4 polyclonal antibody ( 
In vivo tumor metastasis assay
All the animal experiments were carried out in accordance with the animal experimental protocol of the Third Affiliated Hospital of Soochow University, and all the animal experiments were approved by the Animal Ethics Committee of the Third Affiliated Hospital of Soochow University (Soochow, China). Lentiviruses carrying Capn4 or control were designed and packaged by Genechem. Lentiviruses were packaged into HEK293T cells, and stable cell lines were established by infecting lentiviruses into 786-O cells and selected by puromycin. Female nude mice were purchased from Shanghai SLAC Laboratory Animal (Shanghai, China). In the tumor metastasis analysis, 6-week-old nude mice (n = 6) were injected with 786-O cells expressing Capn4 or 786-O control cells, respectively. Briefly, 1 × 10 6 cells were injected intravenously through the tail vein into each mouse in a laminar flow cabinet. Six weeks after injection, the mice were sacrificed, and the metastasis and protein expression levels in tumor tissues were examined.
Statistical analysis
Data are presented as the mean ± SD. All the data analysis was performed by using the GraphPad Prism Software (Version 5.0, La Jolla, USA). Student's t-test was used for the analysis of differences between two groups and one-way analysis of variance was used for the analysis of differences among more than two groups. P < 0.05 was considered statistically significant.
Results
Expression pattern of Capn4 in human kidney proximal tubular cell line and ccRCC cell lines
The mRNA expression levels of Capn4 in normal (HKC) and ccRCC cells were checked first. All the four carcinoma cell lines (786-O, ACHN, Caki-1, and Caki-2) had significantly higher expression levels of Capn4 at mRNA and protein levels than HKC cells (Fig. 1A) . Among the ccRCC cell lines, 786-O cells presented the lowest Capn4 mRNA expression level, while Caki-1 had the highest expression level of Capn4 mRNA (Fig. 1A) . (Fig. 1B,C) . Capn4 siRNA Control: scrambled siRNA. n = 3, significant differences between groups were shown as **P < 0.01 and ***P < 0.001. transfection significantly suppressed the mRNA and protein levels of Capn4 in Caki-1 cells when compared with control siRNA transfection (Fig. 1D,E ).
Capn4 promotes cell invasion and migration in ccRCC cells in vitro
To test the effects of Capn4 on the invasion and migration ability of ccRCC cells, cell adhesion assay, transwell invasion assay, and wound-healing assay were performed accordingly. Cell adhesion assay revealed an apparent decrease in the adhesion activity of 786-O cells transfected with pcDNA3.1-Capn4 when compared with control group (Fig. 2A) . Meanwhile, the number of invaded cells and the wound closure area were increased in 786-O cells transfected with pcDNA3.1-Capn4 (Fig. 2B,C) , indicating that the migratory and invasive abilities were promoted by Capn4 overexpression. On the other hand, for the Caki-1 cells, silencing Capn4 increased the adhesion activity, and attenuated the invasion and migration of Caki-1 cells (Fig. 2D-F) . Taken together, these results showed that Capn4 promoted the migratory and invasive behavior of ccRCC cells in vitro.
Capn4 activates FAK/talin in carcinoma cells
To uncover the mechanism by which Capn4 contributes to invasion and migration in ccRCC cells, western blot analysis was performed to determine the relevant protein levels in 786-O and Caki-1 cells transfected with plasmids or siRNAs. Overexpression of Capn4 increased the protein levels of cleaved talin and p-FAK (pY397), and decreased the protein levels of full-length of talin but had no effect on the protein level of FAK in 786-O cells when compared with control group (Fig. 3A-C) . Consistently, silencing Capn4 downregulated the protein levels of cleaved talin and p-FAK, and increased the protein levels of full-length talin but had no effect on the protein level of FAK in Caki-1 cells (Fig. 3D-F) . The in vitro functional study further showed that FAK-knockdown significantly attenuated the effects of Capn4 overexpression on cell invasion and migration in 786-O cells (Supplementary Fig. S1 ).
Capn4 is involved in the AKT and MAPK signaling in ccRCC cells
The FAK/AKT signaling cascade acts as an essential downstream effector of integrin-focal adhesion interactions, and the effects of Capn4 on the expressions of AKT and MAPK were determined by western blot analysis. Overexpression of Capn4 increased the protein levels of p-AKT and p-MAPK but had no effect on the protein levels of t-AKT and t-MAPK in 786-O cells when compared with control group (Fig. 4A,B) . Consistently, silencing Capn4 down-regulated the protein levels p-AKT and p-MAPK but had no effect on the protein level of t-AKT and t-MAPK in Caki-1 cells (Fig. 4C,D) .
Capn4 affects the expression of invasion-related factors
The FAK signaling has been reported to activate MMP-2 and promote epithelial-mesenchymal transition (EMT) during cancer progression, therefore the effects of Capn4 on the expressions of MMP-2, vimentin, N-cadherin, and E-cadherin were determined by western blot analysis. It was found that Capn4 overexpression significantly up-regulated the protein levels of MMP-2, vimentin, N-cadherin, and down-regulated the protein level of E-cadherin in 786-O cells (Fig. 5A,B) . In addition, Capn4 overexpression also significantly up-regulated the protein level of MMP-9, and down-regulated the protein levels TIMP-1 and TIMP-2 in 786-O cells (Supplementary Fig. S2 ). On the other hand, Capn4 silencing decreased the protein levels of MMP-2, vimentin, Ncadherin, and increased the protein level of E-cadherin in Caki-1 cells (Fig. 5C,D) 
Capn4 promotes metastasis in vivo
To further examine the relationship between Capn4 overexpression and cancer metastasis, we investigated the impact of Capn4 , cell invasion ability (E), and cell migration ability (F) in Caki-1 cells transfected with scrambled siRNA or Capn4 siRNA were determined by cell adhesion, cell invasion, and wound healing assays, respectively. Control: scrambled siRNA. Capn4 silencing increased cell adhesion, suppressed cell invasion and migration in Caki-1 cells. n = 3, significant differences between groups were shown as *P < 0.05 and **P < 0.01. Capn4 silencing decreased the protein levels of p-AKT and p-FAK but had no effect on the protein levels of t-AKT and t-MAPK in Caki-1 cells. Control: scrambled siRNA. n = 3, significant differences between groups were shown as *P < 0.05 and **P < 0.01. overexpression on cancer progression in vivo. The incidence of lung metastases was determined after injection of 786-O cells which expressed either Capn4 or control cells into the tail vein. A significant increase in the number of lung metastases was observed in the Capn4-overexpressing group compared with control group (Fig. 6A,  B) . qRT-PCR and western blot analysis results showed that Capn4 was overexpressed in the lung metastatic nodules of mice injected with 786-O cells expressing Capn4, when compared with the control mice (Fig. 6C,D) . The increased protein levels of cleaved talin, p-FAK, p-AKT, p-MAPK, MMP-2, vimentin, N-cadherin, and the decreased protein levels of full length of talin, E-cadherin were found in the Capn4 group compared with control group (Fig. 6E) .
Discussion
Renal cell carcinoma is the most common malignancy of human kidney cancer. Improvements of therapy have successfully slowed the progression in many patients, but the overall survival remains unsatisfactory. One of the reasons is tumor metastasis. The 5-year survival rates for patients with metastasis are only 8%-12% [15] . As a result, there is a critical clinical need to explore the mechanism of renal cell carcinoma metastasis.
In our previous study, we discovered that the mRNA and protein levels of Capn4 were aberrantly higher in the tumor tissue of ccRCC patients than those in matched adjacent normal tissues. In addition, the mRNA level was positively correlated with the pathological stage, with higher Capn4 level observed in patients with advanced stages. Furthermore, Capn4 mRNA level was also negatively correlated with the overall survival in patients with ccRCC [14] . As a regulatory subunit of calpains, Capn4 plays a role in cell migration and motility through degrading focal adhesions of the attachment sites [16] . In this study, we focused on the functional roles of Capn4, especially on its role in the metastasis.
Tumor metastasis involves multiple sequential steps, including dysregulation of intercellular adhesion, remodeling, and degradation of extracellular matrix, and increasing cell motility [17, 18] . Capn4 has been reported to play a role in invasion and migration of ovarian cancer, lung cancer, breast cancer, and liver cancer [19] [20] [21] [22] . In the present study, we transfected Capn4 overexpression vector or Capn4 siRNA into ccRCC cell lines, and found that downregulating Capn4 expression impaired the invasiveness of ccRCC cells, while Capn4 overexpression increased the cell motility, invasion, and migration. In vivo study also showed that Capn4 promoted metastasis in nude mice. Since Capn4 can degrade focal adhesions at the attachment sites of the cell edges, we also determined the protein expressions of talin, cleaved talin, FAK, and phosphorylated FAK both in vitro and in vivo. It was found that Capn4 overexpression increased the levels of cleaved talin and phosphorylated FAK protein, indicating that the role of Capn4 in ccRCC metastasis is related to adhesion dynamics. The activation of talin/ FAK was reported to promote the phosphorylation of many related substrates involved in the reorganization of actin cytoskeleton and cell migration [23] . Studies have demonstrated that the well-known signaling pathways, i.e. AKT and MAPK signaling pathways, are important downstream cascade of talin/FAK complex [9] . In the present study, we demonstrated that Capn4 overexpression activated the AKT and MAPK signaling, while Capn4 silencing suppressed the activity of AKT and MAPK signaling, suggesting that Capn4 may exert its function in ccRCC via modulation of the AKT and MAPK signaling. However, other signaling cascade may also contribute to Capn4-mediated cancer metastasis in ccRCC.
Among numerous molecules that are associated with cancer metastasis, MMP-2, vimentin, E-cadherin, and N-cadherin are potential substrates for proteolysis mediated by calpains, of which Capn4, as a regulatory subunit, plays a critical role in stability and activity [24] [25] [26] . Talin/FAK signaling has also been reported to promote E-cadherin internalization, which results in promotion of cell motility, inhibition of the endocytic pathway, and activation of MMP-2 during cancer progression [27, 28] . In the present study, Capn4 was found to upregulate the expressions of vimentin, N-cadherin but down-regulate E-cadherin expression, suggesting that Capn4-mediated cancer metastasis may involve EMT. MMP-2 plays important roles in the pathogenesis of various types of cancer. Notably, MMP-2 is associated with metastasis in ccRCC [29] , and knockdown of Capn4 was found to suppress the expression of MMP-2 in nasopharyngeal carcinoma [30] . In addition, Capn4 overexpression up-regulates MMP-2 in intrahepatic cholangiocarcinoma cells [13] . Consistently, our results showed that Capn4 overexpression up-regulated MMP-2 and Capn4 silencing down-regulated MMP-2 in ccRCC cells, suggesting that Capn4 might promote tumor metastasis in ccRCC via up-regulating MMP-2 expression.
In summary, we found that Capn4 promoted in vitro invasion and migration and in vivo metastasis of ccRCC cells. Furthermore, Capn4-mediated cancer metastasis may be related to adhesion dynamics, which may activate metastasis-related signaling cascade in ccRCC cells. The present study provides new insights into the Capn4-mediated cancer metastasis in ccRCC.
Supplementary Data
Supplementary data are available at Acta Biochimica et Biophysica Sinica online.
Funding
